Abstract
In the second edition of the Huntington’s Disease Clinical Trials Corner we list all currently registered and ongoing clinical trials, summarise the top-line results of the recently-announced IONIS-HTTRX trial (NCT02519036), expand on Wave Life Sciences’ PRECISION-HD1 (NCT03225833) and PRECISION-HD2 (NCT03225846), and cover one recently finished trial: the FIRST-HD deutetrabenazine trial (NCT01795859).
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Clinical Trials as Topic*
-
Humans
-
Huntington Disease / drug therapy*
-
Registries / statistics & numerical data
-
Tetrabenazine / analogs & derivatives*
-
Tetrabenazine / therapeutic use
-
Treatment Outcome
Substances
-
deutetrabenazine
-
Tetrabenazine
Associated data
-
ClinicalTrials.gov/NCT02519036
-
ClinicalTrials.gov/NCT03225833
-
ClinicalTrials.gov/NCT03225846
-
ClinicalTrials.gov/NCT01795859